EPO Patent Application: Pharmaceutical Formulation with Echinochrome A Nanofibers
Summary
The European Patent Office has published a new patent application, EP4629966A1, concerning a pharmaceutical formulation incorporating echinochrome A within polymeric micro/nanofibers. The application was published on March 18, 2026, and lists the National and Kapodistrian University of Athens as the applicant.
What changed
This document is a publication of a European patent application (EP4629966A1) for a pharmaceutical formulation developed by the National and Kapodistrian University of Athens. The formulation utilizes polymeric micro/nanofibers to incorporate echinochrome A, a compound with potential therapeutic applications. The publication date is March 18, 2026.
As this is a patent application publication, it does not impose direct compliance obligations on regulated entities. However, it signifies potential future developments in drug delivery systems and pharmaceutical innovation. Companies in the pharmaceutical sector should be aware of this publication as it may relate to emerging technologies or competitive intellectual property in the field of echinochrome A-based therapeutics.
Source document (simplified)
A PHARMACEUTICAL FORMULATION COMPRISING POLYMERIC MICRO-/NANOFIBERS INCORPORATING ECHINOCHROME A
Publication EP4629966A1 Kind: A1 Mar 18, 2026
Applicants
National and Kapodistrian University of Athens
Inventors
ROUSSIS, Vasileios, IOANNOU, Efstathia, KIKIONIS, Stefanos, VALSAMI, Georgia, MAVROGIORGIS, Panagiotis, PAPAKYRIAKOPOULOU, Paraskevi
IPC Classifications
A61K 9/00 20060101AFI20240614BHEP A61K 9/70 20060101ALI20240614BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.